Back
Minerva Neurosciences Vs. Janux Therapeutics Industry Stock Comparison
Sell
45
NERV
Minerva Neurosciences
Last Price:
2.50
Seasonality Move:
22.08%
Buy
69
JANX
Janux Therapeutics
Last Price:
55.36
Seasonality Move:
10.18%
Sell
45
Minerva Neurosciences (NERV)
is a Sell
Is Minerva Neurosciences a Buy, Sell or Hold?
- The current Minerva Neurosciences [NERV] share price is $2.50. The Score for NERV is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- NERV is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
69
Janux Therapeutics (JANX)
is a Buy
Is Janux Therapeutics a Buy, Sell or Hold?
- The current Janux Therapeutics [JANX] share price is $61.44. The Score for JANX is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
- JANX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NERV Stock Price Chart
What is Minerva Neurosciences's stock price today?
-
The Minerva Neurosciences share price today is $2.50
The current trend is relatively stagnant and NERV is experiencing slight buying pressure.
JANX Stock Price Chart
What is Janux Therapeutics's stock price today?
-
The Janux Therapeutics share price today is $61.44
The current trend is moderately bullish and JANX is experiencing slight selling pressure.
NERV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.17 | Sell |
| Relative Strength Index (14 RSI): | 43.22 | Sell |
| Chaikin Money Flow: | 7971 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.4 - 2.54) | Buy |
| Bollinger Bands (100): | (2.36 - 8) | Sell |
JANX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.81 | Buy |
| Relative Strength Index (14 RSI): | 71.4 | Buy |
| Chaikin Money Flow: | -143707 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (41.46 - 58.06) | Buy |
| Bollinger Bands (100): | (9.29 - 46.15) | Buy |
NERV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.4 | Buy |
| 20-day SMA: | 2.45 | Buy |
| 50-day SMA: | 2.57 | Sell |
| 200-day SMA: | 6.09 | Sell |
| 8-day EMA: | 2.41 | Buy |
| 20-day EMA: | 2.49 | Buy |
| 50-day EMA: | 3.25 | Sell |
| 200-day EMA: | 5.18 | Sell |
JANX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 58.7 | Buy |
| 20-day SMA: | 52.93 | Buy |
| 50-day SMA: | 45.26 | Buy |
| 200-day SMA: | 18.72 | Buy |
| 8-day EMA: | 58.99 | Buy |
| 20-day EMA: | 53.2 | Buy |
| 50-day EMA: | 43.45 | Buy |
| 200-day EMA: | 24.63 | Buy |
Minerva Neurosciences Earnings Growth & NERV Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.17 per share, an increase this year of $2.49 per share, and a decrease next year of $1.83 per share.
Janux Therapeutics Earnings Growth & JANX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, an increase next quarter of $0.11 per share, an increase this year of $0.03 per share, and a decrease next year of $0.40 per share.
Minerva Neurosciences Technical Analysis
| Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Janux Therapeutics Technical Analysis
| Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||